Home
SCIENCE
    Capability
        Production
        Analysis
        Q&C
        Regulatory Affairs
    Innovation
        Peptide
        Oligo
        PDC
        Small Molecule
PRODUCTS & SERVICES
    CRDMO
        Peptide NCEs
        Oligonucleotide NCEs
        Small Molecules
        Conjugates
    APIs
        Semaglutide*
        Tirzepatide*
        Liraglutide*
        Lanreotide Acetate
        Octreotide Acetate
        Cetrorelix Acetate
        Desmopressin Acetate
        Eptifibatide
        Bivalirudin
        Ziconotide
        Oseltamivir Phosphate
        Thymalfasin
        Atosiban Acetate
        Edotreotide
        Difelikefalin*
        Dasiglucagon*
        Pegcetacoplan*
        Fulvestrant
        Oxytocin
        Retatrutide*
        Teriparatide
        Setmelanotide*
        Teduglutide
        Atorvastatin Calcium
        Alogliptin Benzoate*
        Sodium Picosulfate
        Epalrestat
        Agomelatine
        Sulindac
        Risdiplam*
        Dydrogesterone
        Ezetimibe
        Roxadustat*
        Rimegepant*
        Ubrogepant*
        Elacestrant*
        AT037
CPG 2216
        AT035
CPG 2007
        AT019
Vutrisiran*
        AT018
Patisiran*
        AT017
Givosiran*
        AT008
Inclisiran*
        AT003
CPG 1018
        AT005
Nusinersen*
    Intermediates
        CAS: 2158301-19-8
        CAS: 1932212-66-2
        CAS: 1107606-68-7
        CAS: 1029716-44-6
        CAS: 1027177-72-5
        CAS: 916420-27-4
        CAS: 875573-67-4
        CAS: 875573-66-3
        CAS: 651324-08-2
        CAS: 204254-96-6
        CAS: 137778-20-2
        CAS: 34381-71-0
        CAS: 20816-79-9
        CAS: 3680-69-1
        CAS: 1459-96-7
    Product Pipeline
NEWS
    News
        Join us in CPHI US & TIDES US
        Keeping up with the trend and showing international perspective - Sinopep in DCAT Week 2024 in New York, USA
        Welcome to 2024 DCAT Week
        Sinopep has obtained FDA First Adequate Letter for Semaglutide
        Sinopep has obtained FDA First Adequate Letter for Liraglutide
        Welcome to 2023 DCAT Week
        Sinopep-Allsino Biopharmaceutical Co Ltd. attended the TIDES EUROPE 2022
        Congratulations: Allsino Chemicals Co. Ltd was awarded the SK Pharmteco Preferred Partner
        Sinopep-Allsino Biopharmaceutical Co Ltd. attended the CPHI Worldwide Frankfurt, Germany
ABOUT US
    Company
    Careers
        校园招聘
        社会招聘
    Contact Us